Eagle pharmaceuticals reports second quarter 2020 results

Eagle pharmaceuticals, inc. (nasdaq: egrx) (“eagle” or the “company”) today announced financial results for the three and six months ended june 30, 20
DECK Ratings Summary
DECK Quant Ranking